Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol
Shoa L Clarke,Rose D L Huang,Austin T Hilliard,Michael G Levin,Disha Sharma,Blake Thomson,Julie Lynch,Philip S Tsao,J Michael Gaziano,Themistocles L Assimes,,Sumitra Muralidha,Jennifer Moser,Jennifer E Deen,Philip S Tsao,Sumitra Muralidhar,J Michael Gaziano,Elizabeth Hauser,Amy Kilbourne,Shiuh-Wen Luoh,Michael Matheny,Dave Oslin,J Michael Gaziano,Philip S Tsao,Lori Churby,Stacey B Whitbourne,Jessica V Brewer,Shahpoor Shayan,Luis E Selva,Saiju Pyarajan,Kelly Cho,Scott L DuVall,Mary T Brophy,Philip S Tsao,Brady Stephens,Themistocles L Assimes,Adriana Hung,Henry Kranzler,Samuel Aguayo,Sunil Ahuja,Kathrina Alexander,Xiao M Androulakis,Prakash Balasubramanian,Zuhair Ballas,Jean Beckham,Sujata Bhushan,Edward Boyko,David Cohen,Louis Dellitalia,L Christine Faulk,Joseph Fayad,Daryl Fujii,Saib Gappy,Frank Gesek,Jennifer Greco,Michael Godschalk,Todd W Gress,Samir Gupta,Salvador Gutierrez,John Harley,Kimberly Hammer,Mark Hamner,Adriana Hung,Robin Hurley,Pran Iruvanti,Frank Jacono,Darshana Jhala,Scott Kinlay,Jon Klein,Michael Landry,Peter Liang,Suthat Liangpunsakul,Jack Lichy,C Scott Mahan,Ronnie Marrache,Stephen Mastorides,Elisabeth Mates,Kristin Mattocks,Paul Meyer,Jonathan Moorman,Timothy Morgan,Maureen Murdoch,James Norton,Olaoluwa Okusaga,Kris Ann Oursler,Ana Palacio,Samuel Poon,Emily Potter,Michael Rauchman,Richard Servatius,Satish Sharma,River Smith,Peruvemba Sriram,Patrick Strollo,Neeraj Tandon,Philip Tsao,Gerardo Villareal,Agnes Wallbom,Jessica Walsh,John Wells,Jeffrey Whittle,Mary Whooley,Allison E Williams,Peter Wilson,Junzhe Xu,Shing Shing Yeh
DOI: https://doi.org/10.1093/eurjpc/zwae271
IF: 8.526
2024-08-19
European Journal of Preventive Cardiology
Abstract:Abstract Aims Elevated lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular disease, but the mechanisms of risk are debated. Studies have found inconsistent associations between Lp(a) and measurements of atherosclerosis. We aimed to assess the relationship between Lp(a), low-density lipoprotein cholesterol (LDL-C), and coronary artery plaque severity. Methods and results The study population consisted of participants of the Million Veteran Program who have undergone an invasive angiogram. The primary exposure was genetically predicted Lp(a) estimated by a polygenic score. Genetically predicted LDL-C was also assessed for comparison. The primary outcome was coronary artery plaque severity categorized as normal, non-obstructive disease, one-vessel disease, two-vessel disease, and three-vessel or left main disease. Among 18 927 adults of genetically inferred European ancestry and 4039 adults of genetically inferred African ancestry, we observed consistent associations between genetically predicted Lp(a) and obstructive coronary plaque, with effect sizes trending upward for increasingly severe categories of disease. Associations were independent of risk factors, clinically measured LDL-C and genetically predicted LDL-C. However, we did not find strong or consistent evidence for an association between genetically predicted Lp(a) and risk for non-obstructive plaque. Conclusion Genetically predicted Lp(a) is positively associated with coronary plaque severity independent of LDL-C, consistent with Lp(a) promoting atherogenesis. However, the effects of Lp(a) may be greater for progression of plaque to obstructive disease than for the initial development of non-obstructive plaque. A limitation of this study is that Lp(a) was estimated using genetic markers and could not be directly assayed nor could apo(a) isoform size.
cardiac & cardiovascular systems